Craig C. Hofmeister
MD, MPH
Dr. Hofmeister's practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance.
Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Biography
Craig C. Hofmeister, MD, MPH, is professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.
Education
Dr. Hofmeister earned his Medical Degree and his Master of Public Health in Clinical Investigation from The Ohio State University in Columbus, Ohio. He completed his internship and hematology fellowship at Loyola University.
Research
Dr. Hofmeister's research focus is on early drug development and investigator-initiated clinical trials exploring novel diagnostics and treatments. As a translational researcher, he has been funded continuously from the National Cancer Institute (NCI) since 2016.
Below is a listing of current federal grants for the above principal investigator.
GrantNumber Title
Publications
Publications Publication Date